332 related articles for article (PubMed ID: 30582762)
41. Aberrant expression of complement regulatory proteins, membrane cofactor protein and decay accelerating factor, in the involved epidermis of patients with vitiligo.
van den Wijngaard RM; Asghar SS; Pijnenborg AC; Tigges AJ; Westerhof W; Das PK
Br J Dermatol; 2002 Jan; 146(1):80-7. PubMed ID: 11841370
[TBL] [Abstract][Full Text] [Related]
42. Differences in the melanosome distribution within the epidermal melanin units and its association with the impairing background of leukoderma in vitiligo and halo nevi: a retrospective study.
Xiong XX; Ding GZ; Zhao WE; Li X; Ling YT; Sun L; Gong QL; Lu Y
Arch Dermatol Res; 2017 Jul; 309(5):323-333. PubMed ID: 28314912
[TBL] [Abstract][Full Text] [Related]
43. A rare repigmentation pattern in a vitiligo patient: a clue to an epidermal stem-cell reservoir of melanocytes?
Davids LM; du Toit E; Kidson SH; Todd G
Clin Exp Dermatol; 2009 Mar; 34(2):246-8. PubMed ID: 18828846
[No Abstract] [Full Text] [Related]
44. New insights into the pathogenesis of vitiligo: imbalance of epidermal cytokines at sites of lesions.
Moretti S; Spallanzani A; Amato L; Hautmann G; Gallerani I; Fabiani M; Fabbri P
Pigment Cell Res; 2002 Apr; 15(2):87-92. PubMed ID: 11936274
[TBL] [Abstract][Full Text] [Related]
45. Epidermal changes in active vitiligo.
Hann SK; Park YK; Lee KG; Choi EH; Im S
J Dermatol; 1992 Apr; 19(4):217-22. PubMed ID: 1607483
[TBL] [Abstract][Full Text] [Related]
46. Immunohistochemical study of perforin and apoptosis stimulation fragment ligand (FasL)in active vitiligo.
Hassan AS; Kohil MM; Sayed SSE; Mahmoud SB
Arch Dermatol Res; 2021 Aug; 313(6):453-460. PubMed ID: 32785835
[TBL] [Abstract][Full Text] [Related]
47. Development of melanocye-keratinocyte co-culture model for controls and vitiligo to assess regulators of pigmentation and melanocytes.
Kumar R; Parsad D; Kanwar A; Kaul D
Indian J Dermatol Venereol Leprol; 2012; 78(5):599-604. PubMed ID: 22960816
[TBL] [Abstract][Full Text] [Related]
48. Effect of PUVA therapy on melanocytes and keratinocytes in non-segmental vitiligo: histopathological, immuno-histochemical and ultrastructural study.
Anbar TS; El-Sawy AE; Attia SK; Barakat MT; Moftah NH; El-Ammawy TS; Abdel-Rahman AT; El-Tonsy MH
Photodermatol Photoimmunol Photomed; 2012 Feb; 28(1):17-25. PubMed ID: 22211999
[TBL] [Abstract][Full Text] [Related]
49. Repigmentation through Melanocyte Regeneration in Vitiligo.
Birlea SA; Goldstein NB; Norris DA
Dermatol Clin; 2017 Apr; 35(2):205-218. PubMed ID: 28317529
[TBL] [Abstract][Full Text] [Related]
50. Vitiligo - The story from within: A transmission electron microscopic study before and after narrow-band ultraviolet B.
Fawzy MM; El Maadawi ZM; Hegazy RA; El Fatah NS
Ultrastruct Pathol; 2016; 40(5):265-75. PubMed ID: 27594347
[TBL] [Abstract][Full Text] [Related]
51. Epidermal reconstructs in vitiligo: an extrinsic factor is needed to trigger the disease.
Bessou S; Gauthier Y; Surlève-Bazeille JE; Pain C; Taïeb A
Br J Dermatol; 1997 Dec; 137(6):890-7. PubMed ID: 9470904
[TBL] [Abstract][Full Text] [Related]
52. Altered E-Cadherin Levels and Distribution in Melanocytes Precede Clinical Manifestations of Vitiligo.
Wagner RY; Luciani F; Cario-André M; Rubod A; Petit V; Benzekri L; Ezzedine K; Lepreux S; Steingrimsson E; Taieb A; Gauthier Y; Larue L; Delmas V
J Invest Dermatol; 2015 Jul; 135(7):1810-1819. PubMed ID: 25634357
[TBL] [Abstract][Full Text] [Related]
53. Autologous melanocyte-keratinocyte suspension in the treatment of vitiligo.
El-Zawahry BM; Zaki NS; Bassiouny DA; Sobhi RM; Zaghloul A; Khorshied MM; Gouda HM
J Eur Acad Dermatol Venereol; 2011 Feb; 25(2):215-20. PubMed ID: 20569286
[TBL] [Abstract][Full Text] [Related]
54. Melanocytes and keratinocytes morphological changes in vitiligo patients. A histological, immunohistochemical and ultrastructural analysis.
Elsherif R; Mahmoud WA; Mohamed RR
Ultrastruct Pathol; 2022 Mar; 46(2):217-235. PubMed ID: 35243959
[TBL] [Abstract][Full Text] [Related]
55. Skin Pigmentation and Pigmentary Disorders: Focus on Epidermal/Dermal Cross-Talk.
Bastonini E; Kovacs D; Picardo M
Ann Dermatol; 2016 Jun; 28(3):279-89. PubMed ID: 27274625
[TBL] [Abstract][Full Text] [Related]
56. Wnt/β-catenin and kit signaling sequentially regulate melanocyte stem cell differentiation in UVB-induced epidermal pigmentation.
Yamada T; Hasegawa S; Inoue Y; Date Y; Yamamoto N; Mizutani H; Nakata S; Matsunaga K; Akamatsu H
J Invest Dermatol; 2013 Dec; 133(12):2753-2762. PubMed ID: 23702581
[TBL] [Abstract][Full Text] [Related]
57. Tenascin is overexpressed in vitiligo lesional skin and inhibits melanocyte adhesion.
Le Poole IC; van den Wijngaard RM; Westerhof W; Das PK
Br J Dermatol; 1997 Aug; 137(2):171-8. PubMed ID: 9292062
[TBL] [Abstract][Full Text] [Related]
58. Effect of Dickkopf1 on the senescence of melanocytes: in vitro study.
Rani S; Chauhan R; Parsad D; Kumar R
Arch Dermatol Res; 2018 May; 310(4):343-350. PubMed ID: 29442138
[TBL] [Abstract][Full Text] [Related]
59. Current Status of Cell-Based Therapies for Vitiligo.
Domaszewska-Szostek A; Polak A; Słupecka-Ziemilska M; Krzyżanowska M; Puzianowska-Kuźnicka M
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834766
[TBL] [Abstract][Full Text] [Related]
60. PIG3V, an immortalized human vitiligo melanocyte cell line, expresses dilated endoplasmic reticulum.
Le Poole IC; Boissy RE; Sarangarajan R; Chen J; Forristal JJ; Sheth P; Westerhof W; Babcock G; Das PK; Saelinger CB
In Vitro Cell Dev Biol Anim; 2000 May; 36(5):309-19. PubMed ID: 10937834
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
